AbbVie Return On Asset vs. Current Valuation

ABBV Stock  USD 174.37  1.30  0.74%   
Based on the measurements of profitability obtained from AbbVie's financial statements, AbbVie's profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess AbbVie's ability to earn profits and add value for shareholders. At this time, AbbVie's Days Sales Outstanding is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.28 in 2024, whereas EV To Sales is likely to drop 4.02 in 2024. At this time, AbbVie's Income Before Tax is fairly stable compared to the past year. Net Income is likely to climb to about 6.3 B in 2024, whereas Operating Income is likely to drop slightly above 9.8 B in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.80.6242
Significantly Up
Slightly volatile
Net Profit Margin0.08510.0895
Notably Down
Slightly volatile
Operating Profit Margin0.320.2349
Significantly Up
Very volatile
Pretax Profit Margin0.110.1151
Sufficiently Down
Slightly volatile
Return On Assets0.03430.0361
Notably Down
Slightly volatile
For AbbVie profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AbbVie to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AbbVie Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AbbVie's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AbbVie Inc over time as well as its relative position and ranking within its peers.
  

AbbVie's Revenue Breakdown by Earning Segment

Check out Trending Equities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
6.2
Earnings Share
2.88
Revenue Per Share
31.397
Quarterly Revenue Growth
0.038
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AbbVie Inc Current Valuation vs. Return On Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AbbVie's current stock value. Our valuation model uses many indicators to compare AbbVie value to that of its competitors to determine the firm's financial worth.
AbbVie Inc is rated third in return on asset category among its peers. It is the top company in current valuation category among its peers reporting about  4,868,108,378,653  of Current Valuation per Return On Asset. Comparative valuation analysis is a catch-all technique that is used if you cannot value AbbVie by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

AbbVie Current Valuation vs. Return On Asset

Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

AbbVie

Return On Asset

 = 

Net Income

Total Assets

 = 
0.0772
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

AbbVie

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
375.82 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

AbbVie Current Valuation vs Competition

AbbVie Inc is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 394.78 Billion. AbbVie totals roughly 375.82 Billion in current valuation claiming about 95% of equities under Health Care industry.

AbbVie Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in AbbVie, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AbbVie will eventually generate negative long term returns. The profitability progress is the general direction of AbbVie's change in net profit over the period of time. It can combine multiple indicators of AbbVie, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-2.3 B-2.4 B
Operating Income12.8 B9.8 B
Income Before Tax6.2 B7.3 B
Total Other Income Expense Net-6.5 B-6.2 B
Net Income4.9 B6.3 B
Income Tax Expense1.4 B1.2 B
Net Income Applicable To Common Shares13.6 B14.3 B
Net Income From Continuing Ops4.9 B6.9 B
Non Operating Income Net Other-2.3 B-2.5 B
Interest Income540 M567 M
Net Interest Income-1.7 B-1.8 B
Change To NetincomeB3.4 B
Net Income Per Share 2.75  2.80 
Income Quality 4.69  4.92 
Net Income Per E B T 0.78  0.70 

AbbVie Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on AbbVie. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AbbVie position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AbbVie's important profitability drivers and their relationship over time.

Use AbbVie in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie will appreciate offsetting losses from the drop in the long position's value.

AbbVie Pair Trading

AbbVie Inc Pair Trading Analysis

The ability to find closely correlated positions to AbbVie could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie Inc to buy it.
The correlation of AbbVie is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your AbbVie position

In addition to having AbbVie in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Coal Thematic Idea Now

Coal
Coal Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Coal theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Coal Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.